Innovation
3 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 81 times.
| Year | Filings |
|---|---|
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Investor mix
8 investors on record; lead investors include Regeneron Pharmaceuticals, Invest-NL.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 50% |
| Private equity | 2 | 25% |
| Other / undisclosed | 2 | 25% |